Institutional

About Putnam Franklin Templeton Contact us

Mental health:
Insights and potential investment implications

Download the research

The COVID-19 pandemic has put a spotlight on issues related to mental health. Although it is too soon to draw conclusions, we believe several clear trends have emerged during the pandemic — some worrisome, some promising. Our new report explores these developments and the potential implications for investors.

Understanding the cost of mental illness

Mental health is an essential challenge

As individuals, we are undoubtedly concerned for the health of friends, family, and society as a whole. But as investors, we also pay attention to the direct and indirect costs of mental health.

From the effects of COVID-19 to what government and business leaders are doing to address the problem, several trends in treating mental health are emerging. We explore these developments in our report.

What is the true cost – both direct and indirect – of mental illness in the United States?

The costs of mental illness

Although nearly one in five adults in the United States lives with mental illness (or 46.6 million people in 2017), several barriers hinder access to mental healthcare. These include inadequate healthcare coverage, high out-of-pocket expenses for patients, a shortage of providers, and lingering stigma.

Depression, anxiety, and other mental illness carry with them significant costs both in the form of direct healthcare costs and through broader societal costs.

43% of Americans
with a mental health issue
received treatment in 2017*

$280.5B is estimated
to be spent on mental health and
substance use disorders in 2020**

Employers increasingly recognize the benefits of reducing both the suffering and the costs of mental illness, and investors recognize the possibilities associated with expanding treatment.

Download the research

The impact of the COVID-19 pandemic on mental health

Many mental health experts have warned that the stress and isolation associated with the pandemic and quarantine conditions could further accelerate the prevalence and intensity of mental illnesses. During the pandemic, Americans are reporting significantly higher levels of stress, especially parents with children at home.

In June 2020, CDC found 41% of respondents reported an adverse mental health condition, with 31% suffering from anxiety or depression.^†

What are the potential long-term implications?

How are the healthcare system and businesses responding?

Download the research

Learn more when you download the full report

Gain insights about the potential meaningful benefits for society and for businesses that could come with expanding treatment, and learn about investment opportunities among companies providing solutions.

Download the research

* Source: National Institute of Mental Health
** Source: Projections of National Expenditures for Treatment of Mental Health and Substance Abuse Disorders, 2010-2020, Substance Abuse and Mental Health Services Administration.
† CDC Morbidity and Mortality Weekly Report, Vol. 69, No. 32, August 14, 2020.

Investment capabilities

UCITS Funds

Latest perspective

Current views

Login for portfolio details and reports

Personalized dashboard

Portfolio details

Reports

Mental health:
Insights and potential investment implications

Download the research

Understanding the cost of mental illness

Mental health is an essential challenge

As individuals, we are undoubtedly concerned for the health of friends, family, and society as a whole. But as investors, we also pay attention to the direct and indirect costs of mental health.

From the effects of COVID-19 to what government and business leaders are doing to address the problem, several trends in treating mental health are emerging. We explore these developments in our report.

What is the true cost – both direct and indirect – of mental illness in the United States?

The costs of mental illness

Depression, anxiety, and other mental illness carry with them significant costs both in the form of direct healthcare costs and through broader societal costs.

43% of Americans
with a mental health issue
received treatment in 2017*

$280.5B is estimated
to be spent on mental health and
substance use disorders in 2020**

Employers increasingly recognize the benefits of reducing both the suffering and the costs of mental illness, and investors recognize the possibilities associated with expanding treatment.

The impact of the COVID-19 pandemic on mental health

In June 2020, CDC found 41% of respondents reported an adverse mental health condition, with 31% suffering from anxiety or depression.^†

What are the potential long-term implications?

How are the healthcare system and businesses responding?

Learn more when you download the full report

Gain insights about the potential meaningful benefits for society and for businesses that could come with expanding treatment, and learn about investment opportunities among companies providing solutions.

Investment capabilities

UCITS Funds

Latest perspective

Current views

Login for portfolio details and reports

Personalized dashboard

Portfolio details

Reports

Mental health:Insights and potential investment implications

Download the research

Understanding the cost of mental illness

Mental health is an essential challenge

As individuals, we are undoubtedly concerned for the health of friends, family, and society as a whole. But as investors, we also pay attention to the direct and indirect costs of mental health.

From the effects of COVID-19 to what government and business leaders are doing to address the problem, several trends in treating mental health are emerging. We explore these developments in our report.

What is the true cost – both direct and indirect – of mental illness in the United States?

The costs of mental illness

Depression, anxiety, and other mental illness carry with them significant costs both in the form of direct healthcare costs and through broader societal costs.

43% of Americans with a mental health issuereceived treatment in 2017*

$280.5B is estimated to be spent on mental health andsubstance use disorders in 2020**

Employers increasingly recognize the benefits of reducing both the suffering and the costs of mental illness, and investors recognize the possibilities associated with expanding treatment.

The impact of the COVID-19 pandemic on mental health

In June 2020, CDC found 41% of respondents reported an adverse mental health condition, with 31% suffering from anxiety or depression.†

What are the potential long-term implications?

How are the healthcare system and businesses responding?

Learn more when you download the full report

Gain insights about the potential meaningful benefits for society and for businesses that could come with expanding treatment, and learn about investment opportunities among companies providing solutions.

Mental health:
Insights and potential investment implications

43% of Americans
with a mental health issue
received treatment in 2017*

$280.5B is estimated
to be spent on mental health and
substance use disorders in 2020**

In June 2020, CDC found 41% of respondents reported an adverse mental health condition, with 31% suffering from anxiety or depression.^†